The role of uterine and vaginal microbiome affecting the outcomes of assisted reproductive technologies
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.592
Abstract
Infertility is a high-priority medical and social issue, which prevalence reaches 15 % according to the World Health Organization. One of the methods for infertility treatment, which is often resorted to by sub-fertile couples, is the use of assisted reproductive technologies (ART). It is known that the microbiome of the uterine cavity and vagina can affect ART-related fertility potential. The normal vaginal microbiome is characterized by the dominance of Lactobacillus spp. representatives, which ensure the maintenance of optimal pH values and prevent pathogenic microbial penetration and multiplication. It is assumed that the normal endometrial microbiome is characterized by predominance of Lactobacillus spp., but relevant studies are prominently heterogeneous. According to the current hypothesis, the dominance of Lactobacillus spp. and, particularly, Lactobacillus crispatus, in the vagina and uterine cavity is associated with favorable reproductive outcomes in ART programs. Recurrent implantation failures are related to spreading of opportunistic microflora in such niches. Nevertheless, some authors have reported no direct correlation between Lactobacillus spp. level, presence of opportunistic microorganisms and favorable outcomes of ART programs, which underlies a need to conduct further large-scale studies.
About the Authors
K. R. BakhtiyarovRussian Federation
Kamil R. Bakhtiyarov, MD, Dr Sci Med, Prof.
Scopus Author ID: 57208396965
8 bldg. 2, Trubetskaya Str., Moscow 119048
I. V. Ignatko
Russian Federation
Irina V. Ignatko, MD, Dr Sci Med, Prof., Corresponding Member of RAS
Scopus Author ID: 15118951800
WoS ResearcherID: H-2442-2018
8 bldg. 2, Trubetskaya Str., Moscow 119048
A. S. Zueva
Russian Federation
Alina S. Zueva, MD
Scopus Author ID: 59132162700
WoS ResearcherID: JWO-2945-2024
8 bldg. 2, Trubetskaya Str., Moscow 119048
E. V. Siniakova
Russian Federation
Elizaveta V. Siniakova
Scopus Author ID: 59411067300
WoS ResearcherID: ABH-4680-2022
8 bldg. 2, Trubetskaya Str., Moscow 119048
T. D. Kapyrina
Russian Federation
Tatyana D. Kapyrina, MD
Scopus Author ID: 58631437000
8 bldg. 2, Trubetskaya Str., Moscow 119048
References
1. Shermukhamedova M.P., Khomidova G.Zh., Nasriddinova K.P. Modern approaches to the diagnosis and treatment of female infertility. [Sovremennye podhody k diagnostike i lecheniyu zhenskogo besplodiya]. Ekonomika i socium. 2022;(1–2):408–12. (In Russ.).
2. Li P., Wei K., He X. et al. Vaginal probiotic Lactobacillus crispatus seems to inhibit spem activity and subsequently reduces pregnancies in rat. Front Cell Dev Bioly. 2021;9:705690. https://doi.org/10.3389/fcell.2021.705690.
3. V?in?m? S., Saqib S., Kalliala I. et al. Longitudinal analysis of vaginal microbiota during IVF fresh embryo transfer and in early pregnancy. Microbiol Spectr. 2023;11(6):e0165023. https://doi.org/10.1128/spectrum.01650-23.
4. Tian Q., Jin S., Zhang G. et al. Assessing vaginal microbiome through Vaginal Microecology Evaluation System as a predictor for in vitro fertilization outcomes: a retrospective study. Front Endocrinol. 2024:9(15):1380187. https://doi.org/10.3389/fendo.2024.1380187.
5. Rudakova E.B., Strizhova T.V., Fedorova E.A. et al. The maternal factors of failures and defects of implantation after IVF. [Materinskie faktory riska neudach i defektov implantacii posle EKO]. Medicinskij sovet. 2020;(13):166–78. (In Russ.). https://doi.org/10.21518/2079-701X-2020-13-166-178.
6. Podzolkova N.M., Shamugia N.L., Varlakova P.M. The role of endometrial factor in recurrent implantation failure (literature review). [Rol' faktora endometriya v povtornyh neudachah implantacii (obzor literatury)]. Medicinskij alfavit. 2023;(3):30–6. (In Russ.). https://doi.org/10.33667/2078-5631-2023-3-30-36.
7. Barrientos-Dur?n A., Fuentes-L?pez A., de Salazar A. et al. Reviewing the composition of vaginal microbiota: inclusion of nutrition and probiotic factors in the maintenance of eubiosis. Nutrients. 2020;12(2):419. https://doi.org/10.3390/nu12020419.
8. Foteinidou P., Exindari M., Chatzidimitriou D., Gioula G. Endometrial microbiome and its correlation to female infertility: a systematic review and meta-analysis. Acta Microbiologica Hellenica. 2024;69(1):14–28. https://doi.org/10.3390/amh69010004.
9. Elkafas H., Walls M., Al-Hendy A., Ismail N. Gut and genital tract microbiomes: dysbiosis and link to gynecological disorders. Front Cell Infect Microbiol. 2022;12:1059825. https://doi.org/10.3389/fcimb.2022.1059825.
10. Wensel C.R., Pluznick J.L., Salzberg S.L., Sears C.L. Next-generation sequencing: insights to advance clinical investigations of the microbiome. J Clin Invest. 2022;132(7):e154944. https://doi.org/10.1172/JCI154944.
11. Sola-Leyva A., Andr?s-Le?n E., Molina N.M. et al. Mapping the entire functionally active endometrial microbiota. Hum Reprod. 2021;36(4):1021–31. https://doi.org/10.1093/humrep/deaa372.
12. Vanstokstraeten R., Callewaert E., Blotwijk S. et al. Comparing vaginal and endometrial microbiota using culturomics: proof of concept. Int J Mol Sci. 2023;24(6):5947. https://doi.org/10.3390/ijms24065947.
13. Gao X., Louwers Y.V., Laven J.S.E., Schoenmakers S. Clinical relevance of vaginal and endometrial microbiome investigation in women with repeated implantation failure and recurrent pregnancy loss. Int J Mol Sci. 2024;25(1):622. https://doi.org/10.3390/ijms25010622.
14. Carosso A., Revelli A., Gennarelli G. et al. Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study. J Assist Reprod Genet. 2020;37(9):2315–26. https://doi.org/10.1007/s10815-020-01878-4.
15. Kyono K., Hashimoto T., Nagai Y., Sakuraba Y. Analysis of endometrial microbiota by 16S ribosomal RNA gene sequencing among infertile patients: a single-center pilot study. Reprod Med Biol. 2018;17(3):297–306. https://doi.org/10.1002/rmb2.12105.
16. Ji L., Peng C., Bao X. Effect of vaginal flora on clinical outcome of frozen embryo transfer. Front Cell Infect Microbiol. 2022;12:987292. https://doi.org/10.3389/fcimb.2022.987292.
17. Lledo B., Fuentes A., Lozano F. M. et al. Identification of vaginal microbiome associated with IVF pregnancy. Sci Rep. 2022;12(1):6807. https://doi.org/10.1038/s41598-022-10933-2.
18. Ravel J., Gajer P., Abdo Z. et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108 Suppl 1(Suppl 1):4680–7. https://doi.org/10.1073/pnas.1002611107.
19. France M.T., Ma B., Gajer P. et al. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8:166. https://doi.org/10.1186/s40168-020-00934-6.
20. Hugerth L.W., Krog M.C., Vomstein K. et al. Defining Vaginal Community Dynamics: daily microbiome transitions, the role of menstruation, bacteriophages, and bacterial genes. Microbiome. 2024;12(1):153. https://doi.org/10.1186/s40168-024-01870-5.
21. Haahr T., Jensen J.S., Thomsen L. et al. Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients. Hum Reprod. 2016;31(4):795–803. https://doi.org/10.1093/humrep/dew026.
22. Lebedeva O.P., Popov V.N., Syromyatnikov M.Y. et al. Female reproductive tract microbiome and early miscarriages. APMIS. 2023;131(2):61–76. https://doi.org/10.1111/apm.13288.
23. Fu M., Zhang X., Liang Y. et al. Alterations in vaginal microbiota and associated metabolome in women with recurrent implantation failure. mBio. 2020;11(3):e03242-19. https://doi.org/10.1128/mBio.03242-19.
24. Lledo B., Fuentes A., Lozano F.M. et al. Identification of vaginal microbiome associated with IVF pregnancy. Sci Rep. 2022;12(1):6807. https://doi.org/10.1038/s41598-022-10933-2.
25. Wang R., Zhou G., Wu L. et al. The microbial composition of lower genital tract may affect the outcome of in vitro fertilization-embryo transfer. Front Microbiol. 2021;12:729744. https://doi.org/10.3389/fmicb.2021.729744.
26. Su W., Gong C., Zhong H. et al. Vaginal and endometrial microbiome dysbiosis associated with adverse embryo transfer outcomes. Reprod Biol Endocrinol. 2024;22(1):111. https://doi.org/10.1186/s12958-024-01274-y.
27. Koedooder R., Singer M., Schoenmakers S. et al. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study. Hum Reprod. 2019;34(6):1042–54. https://doi.org/10.1093/humrep/dez065.
28. Wang J., Li Z., Ma X. et al. Translocation of vaginal microbiota is involved in impairment and protection of uterine health. Nat Commun. 2021:12(1):4191. https://doi.org/10.1038/s41467-021-24516-8.
29. Tomaiuolo R., Veneruso I., Cariati F., D'Argenio V. Microbiota and human reproduction: the case of female infertility. High Throughput. 2020;9(2):12. https://doi.org/10.3390/ht9020012.
30. Moreno I., Garcia-Grau I., Perez-Villaroya D. et al. Endometrial microbiota сomposition is associated with reproductive outcome in infertile patients. Microbiome. 2022;10(1):1. https://doi.org/10.1186/s40168-021-01184-w.
31. Chen Q., Zhang X., Hu Q. et al. The alteration of intrauterine microbiota in chronic endometritis patients based on 16S rRNA sequencing analysis. Ann Clin Microbiol Antimicrob. 2023;22(1):4. https://doi.org/10.1186/s12941-023-00556-4.
32. Leoni C., Ceci O., Manzari C. et al. Human endometrial microbiota at term of normal pregnancies. Genes. 2019;10(12):971. https://doi.org/10.3390/genes10120971.
33. Moreno I., Codo?er F.M., Vilella F. et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;6(215):684–703. https://doi.org/10.1016/j.ajog.2016.09.075.
34. Kaluanga Bwanga P., Tremblay-Lemoine P.L., Timmermans M. et al. The endometrial microbiota: challenges and prospects. Medicina. 2023;59(9):1540. https://doi.org/10.3390/medicina59091540.
35. Li F., Chen C., Wei W. et al. The metagenome of the female upper reproductive tract. Gigascience. 2018;7(10):giy107. https://doi.org/10.1093/gigascience/giy107.
36. Wang W., Feng D., Ling B. Biologia Futura: endometrial microbiome affects endometrial receptivity from the perspective of the endometrial immune microenvironment. Biol Futur. 2022;73(3):291–300. https://doi.org/10.1007/s42977-022-00134-3.
37. Zheng N., Guo R., Wang J. et al. Contribution of Lactobacillus iners to vaginal health and diseases: a systematic review. Front Cell Infect Microbiol. 2021;11:792787. https://doi.org/10.3389/fcimb.2021.792787.
38. Zhang H., Zou H., Zhang C., Zhang S. Chronic endometritis and the endometrial microbiota: implications for reproductive success in patients with recurrent implantation failure. Ann Clin Microbiol Antimicrob. 2024;23(1):49. https://doi.org/10.1186/s12941-024-00710-6.
39. Cariati F., Carotenuto C., Bagnulo F. et al. Endometrial microbiota profile in in-vitro fertilization (IVF) patients by culturomics-based analysis. Front Endocrinol. 2023;14:1204729. https://doi.org/10.3389/fendo.2023.1204729.
40. Barinova V.V., Kuznetsova N.B., Bushtyreva I.O. et al. Endometrial microbiome in women with multiple failed in vitro fertilization cycles. [Mikrobiom endometriya u zhenshchin s mnogokratnymi neudachami ekstrakorporal'nogo oplodotvoreniya]. Voprosy ginekologii, akusherstva i perinatologii. 2021;20(3):5–11. (In Russ.). https://doi.org/10.20953/1726-1678-2021-3-5-11.
41. Barinova V.V., Kuznetsova N.B., Bushtyreva I.O. et al. Endometrial microbiome in women with and without a history of repeated failures of assisted reproductive technology: what are norm and pathology? [Mikrobiom endometriya pri mnogokratnyh neudachah vspomogatel'nyh reproduktivnyh tekhnologij i u zdorovyh zhenshchin: gde norma i gde patologiya?] Akusherstvo i ginekologiya. 2021;(6):105–14. (In Russ.). https://doi.org/10.18565/aig.2021.6.105-114.
42. Tursunova N.B., Lebedeva O.P., Altukhova O.B., Nagorny A.V. An updated view on the role of the female reproductive tract microbiome in IVF outcomes. [Sovremennyj vzglyad na rol' mikrobioma zhenskogo reproduktivnogo trakta v iskhodah EKO]. Obstetrics, Gynecology and Reproduction. 2023;17(4):512–25. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.433.
43. Kutsenko I.I., Borovikov I.O., Kravtsova E.I. et al. Vaginal and endometrial microbiome: evaluation, effect on embryo implantation. [Vaginal'nyj i endometrial'nyj mikrobiom: ocenka, vliyanie na implantaciyu embriona]. Medicinskij vestnik Yuga Rossii. 2023;14(3):5–15. (In Russ.). https://doi.org/10.21886/2219-8075-2023-14-3-5-15.
44. Keburiya L.K., Smolnikova V.Y., Priputnevich T.V. et al. Does the uterine microbiota affect the reproductive outcomes in women with recurrent implantation failures? BMC Womens Health. 2022;22(1):168. https://doi.org/10.1186/s12905-022-01750-w.
What is already known about this subject?
► The causes of infertility include genetic, anatomical, endocrine, immunological and microbiological factors. One of the ways to overcome infertility is to use assisted reproductive technologies (ART), with overall effectiveness comprising about 45 %.
► Five vaginal community state types (CST) have been identified in the vaginal microbiome. CST1 is considered the most favorable for the onset of clinical pregnancy.
► The normal species composition of the uterine microbiota has not been defined. It is unknown whether the microorganisms detected are permanent uterine inhabitants or accidentally introduced due to transvaginal manipulation.
What are the new findings?
► New data on the role of Lactobacillus spp. and opportunistic microorganisms in the uterine and vaginal microbiome for successful pregnancy and repeated implantation failure (RIF) are presented.
► Among new methods to study an effect of the vaginal and uterine microbiome on ART outcomes, 16S rRNA sequencing, whole metagenomic sequencing, metabolomics, and cultureomics have been used.
► The microbiota of the female reproductive tract is able to affect local immune reactions in the uterine cavity, affecting embryo implantation.
How might it impact on clinical practice in the foreseeable future?
► Investigating reproductive microbiome will help to predict pregnancy success in ART programs, as well as to reduce infertility-related RIF number of microbiological etiology.
Review
For citations:
Bakhtiyarov K.R., Ignatko I.V., Zueva A.S., Siniakova E.V., Kapyrina T.D. The role of uterine and vaginal microbiome affecting the outcomes of assisted reproductive technologies. Obstetrics, Gynecology and Reproduction. 2025;19(2):273-281. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.592

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.